Humanigen's Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer Study

Vandana Singh

Fri, Apr 9, 2021, 8:28 AM1 min read

Humanigen Inc (NASDAQ: HGEN) has announced results from the Phase 1 trial evaluating its second Humaneered antibody, ifabotuzumab, in patients with glioblastoma multiforme (GBM), the most frequent and lethal primary brain cancer.
The results will be presented as a poster at the AACR Annual Meeting 2021.
In the study, ifabotuzumab demonstrated highly sensitive, specific, and reproducible targeting of the tumor and tumor microenvironment in all patients.
No dose-limiting toxicities were observed, and all adverse events were readily manageable.
The Phase 1 study was designed to determine the safety and recommended Phase 2 dose of ifabotuzumab.
Ifabotuzumab is a non-fucosylated IgG1κ antibody targeting the EphA3 receptor. EphA3 is a tumor-restricted antigen expressed in the tumor vasculature and tumor stroma of various solid tumors.
Additional studies are planned to evaluate ifabotuzumab as an antibody-drug conjugate in solid tumor patients.
Price Action: HGEN shares are trading 2.8% higher at $17.4 in the premarket session on the last check Friday.

See more from Benzinga

When I Claim My $4,000 Social Security, Will My Wife Automatically Get a Spousal Benefit?
My wife is 76, born in 1948. She retired at full retirement age and currently collects $1,076 per month. I will be retiring and start collecting at 70 this year (I was born in 1954). When I collect $4,000+ per month does her monthly payment go up to spousal benefit automatically or does it have […] The post When I Claim My $4,000 Social Security, Will My Wife Automatically Get a Spousal Benefit? appeared first on SmartReads by SmartAsset.
SmartAsset
Palantir Slides After Annual Sales Forecast Fails to Impress
(Bloomberg) -- Palantir Technologies Inc. shares slid in extended trading on Monday as the market appeared unimpressed by the company’s outlook for annual sales after the stock has tripled in the past year.Most Read from BloombergIsrael Says a Cease-Fire Plan Backed by Hamas Falls Far ShortAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJack Dorsey Leaves Bluesky Board, Calls X ‘Freedom Technology’Ex-Trump Controller Says Cohen Repaid From Personal AccountS&P 500 Extends Gains in
Bloomberg
The Federal Reserve Just Indicated Social Security Could Get a Bigger 2025 Cost-of-Living Adjustment (COLA) Than Expected
A bigger COLA may sound great, but it has some big drawbacks for retirees too.
Motley Fool
Palantir Earnings Crush Estimates. The Stock Still Slips Following Big Run.
Palantir followed up its “bombastic” December quarter with even better results for the March quarter as the data analytics software company continued to gain traction with its artificial intelligence tools in particular with U.S. commercial customers. Palantir shares, which rallied 8.1% in Monday’s regular session, was off about 4 % in after-hours trading. For the March quarter, Palantir posted revenue of $634 million, up 21% from a year ago, and ahead of both the company’s guidance range of $612 million to $616 million and Wall Street’s consensus of $615 million as tracked by FactSet.
Barrons.com
Warren Buffett Bought $9.2 Billion of This Stock Last Year, and He Could Buy Even More in 2024
One of Buffett's favorite stocks of all time topped his list of buys in 2023.
Motley Fool
Elon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Here's Who I Think It Is and Why I See Tesla Stock as the Better Buy.
During Tesla's first-quarter earnings call, investors learned that the company is exploring licensing opportunities in autonomous driving.
Motley Fool
GE Stock Soars 110% To A 15-Year High — Is GE Aerospace A Buy?
General Electric officially split into GE Aerospace and GE Vernova in April. GE Aerospace now trades at its best level since the 2008 meltdown.
Investor's Business Daily
Seeking at Least 8% Dividend Yield? Analysts Offer 2 Dividend Stocks to Buy
The last inflation report, which came in worse than expected, had investors worried about the Federal Reserve’s plans for interest rates this year. The central bank held rates steady in its most recent decision, cooling fears that a hike is in the offing. When combined with moderate gains in the Q1 earnings reports, it makes sense that we saw stocks rebounding as confidence in the market was restored. However, according to JPMorgan’s chief market strategist Marko Kolanovic, we’re not out of the
TipRanks
$3 trillion could be injected into the U.S. economy without any federal spending by tweaking this corner of the mortgage market, ‘Oracle of Wall Street’ says
"Rarely have I seen such a true win-win scenario for the government, Wall Street and the U.S. consumer."
Fortune
Palantir raises 2024 forecast on robust AI demand
Data analytics firm Palantir Technologies raised its annual revenue and profit forecast and beat first-quarter sales estimates on Monday, riding on strong demand for its services that help businesses deploy artificial intelligence applications. The company has emerged as a winner of the generative AI boom thanks to its artificial intelligence platform, which is used to test and debug code and help evaluate AI-related scenarios, among other uses. "AIP is driving a huge part of both our new customers and growth within existing customers and its having a huge impact on our business," chief revenue officer Ryan Taylor told Reuters.
Reuters

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Humanigen's Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer Study

Recommended Stories

When I Claim My $4,000 Social Security, Will My Wife Automatically Get a Spousal Benefit?

Palantir Slides After Annual Sales Forecast Fails to Impress

The Federal Reserve Just Indicated Social Security Could Get a Bigger 2025 Cost-of-Living Adjustment (COLA) Than Expected

Palantir Earnings Crush Estimates. The Stock Still Slips Following Big Run.

Warren Buffett Bought $9.2 Billion of This Stock Last Year, and He Could Buy Even More in 2024

Elon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Here's Who I Think It Is and Why I See Tesla Stock as the Better Buy.

GE Stock Soars 110% To A 15-Year High — Is GE Aerospace A Buy?

Seeking at Least 8% Dividend Yield? Analysts Offer 2 Dividend Stocks to Buy

$3 trillion could be injected into the U.S. economy without any federal spending by tweaking this corner of the mortgage market, ‘Oracle of Wall Street’ says

Palantir raises 2024 forecast on robust AI demand